Oleic acid biosynthesis in Plasmodium falciparum: Characterization of the stearoyl-CoA desaturase and investigation as a potential therapeutic target

Paul Gratraud, Enlli Huws, Brie Falkard, Sophie Adjalley, David A. Fidock, Laurence Berry, William R. Jacobs, Mark S. Baird, Henri Vial, Laurent Kremer

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Background: Plasmodium falciparum parasitization of erythrocytes causes a substantial increase in the levels of intracellular fatty acids, notably oleic acid. How parasites acquire this monounsaturated fatty acid has remained enigmatic. Here, we report on the biochemical and enzymatic characterization of stearoyl-CoA desaturase (SCD) in P. falciparum. Methodology/Principal Findings: Metabolic labeling experiments allowed us to demonstrate the production of oleic acid from stearic acid both in lysates of parasites incubated with [14C]-stearoyl-CoA and in parasite-infected erythrocytes labeled with [14C]-stearic acid. Optimal SCD activity was detected in schizonts, the stage of maximal membrane synthesis. This activity correlated with a late trophozoite stage-specific induction of PFE0555w transcripts. PFE0555w harbors a typical SCD signature. Similar to mammalian SCDs, this protein was found to be associated with the endoplasmic reticulum, as determined with PFE0555w-GFP tagged transgenic P. falciparum. Importantly, these parasites exhibited increased rates of stearic to oleic acid conversion, providing additional evidence that PFE0555w encodes the plasmodial SCD (PfSCD). These findings prompted us to assess the activity of sterculic acid analogues, known to be specific Δ9-desaturase inhibitors. Methyl sterculate inhibited the synthesis of oleic acid both with parasite lysates and infected erythrocytes, most likely by targeting PfSCD. This compound exhibited significant, rapid and irreversible antimalarial activity against asexual blood stages. This parasiticidal effect was antagonized by oleic acid. Conclusion/Significance: Our study provides evidence that parasite-mediated fatty acid modification is important for blood-stage survival and provides a new strategy to develop a novel antimalarial therapeutic based on the inhibition of PfSCD.

Original languageEnglish (US)
Article numbere6889
JournalPloS one
Volume4
Issue number9
DOIs
StatePublished - Sep 3 2009

Fingerprint

Stearoyl-CoA Desaturase
stearoyl-CoA desaturase
Biosynthesis
Plasmodium falciparum
Oleic Acid
oleic acid
Parasites
biosynthesis
parasites
therapeutics
antimalarials
erythrocytes
Erythrocytes
Antimalarials
stearic acid
sterculic acid
Blood
Fatty Acids
Therapeutics
Schizonts

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • General

Cite this

Oleic acid biosynthesis in Plasmodium falciparum : Characterization of the stearoyl-CoA desaturase and investigation as a potential therapeutic target. / Gratraud, Paul; Huws, Enlli; Falkard, Brie; Adjalley, Sophie; Fidock, David A.; Berry, Laurence; Jacobs, William R.; Baird, Mark S.; Vial, Henri; Kremer, Laurent.

In: PloS one, Vol. 4, No. 9, e6889, 03.09.2009.

Research output: Contribution to journalArticle

Gratraud, Paul ; Huws, Enlli ; Falkard, Brie ; Adjalley, Sophie ; Fidock, David A. ; Berry, Laurence ; Jacobs, William R. ; Baird, Mark S. ; Vial, Henri ; Kremer, Laurent. / Oleic acid biosynthesis in Plasmodium falciparum : Characterization of the stearoyl-CoA desaturase and investigation as a potential therapeutic target. In: PloS one. 2009 ; Vol. 4, No. 9.
@article{ea4fad05a71445eb87698f75e68231c6,
title = "Oleic acid biosynthesis in Plasmodium falciparum: Characterization of the stearoyl-CoA desaturase and investigation as a potential therapeutic target",
abstract = "Background: Plasmodium falciparum parasitization of erythrocytes causes a substantial increase in the levels of intracellular fatty acids, notably oleic acid. How parasites acquire this monounsaturated fatty acid has remained enigmatic. Here, we report on the biochemical and enzymatic characterization of stearoyl-CoA desaturase (SCD) in P. falciparum. Methodology/Principal Findings: Metabolic labeling experiments allowed us to demonstrate the production of oleic acid from stearic acid both in lysates of parasites incubated with [14C]-stearoyl-CoA and in parasite-infected erythrocytes labeled with [14C]-stearic acid. Optimal SCD activity was detected in schizonts, the stage of maximal membrane synthesis. This activity correlated with a late trophozoite stage-specific induction of PFE0555w transcripts. PFE0555w harbors a typical SCD signature. Similar to mammalian SCDs, this protein was found to be associated with the endoplasmic reticulum, as determined with PFE0555w-GFP tagged transgenic P. falciparum. Importantly, these parasites exhibited increased rates of stearic to oleic acid conversion, providing additional evidence that PFE0555w encodes the plasmodial SCD (PfSCD). These findings prompted us to assess the activity of sterculic acid analogues, known to be specific Δ9-desaturase inhibitors. Methyl sterculate inhibited the synthesis of oleic acid both with parasite lysates and infected erythrocytes, most likely by targeting PfSCD. This compound exhibited significant, rapid and irreversible antimalarial activity against asexual blood stages. This parasiticidal effect was antagonized by oleic acid. Conclusion/Significance: Our study provides evidence that parasite-mediated fatty acid modification is important for blood-stage survival and provides a new strategy to develop a novel antimalarial therapeutic based on the inhibition of PfSCD.",
author = "Paul Gratraud and Enlli Huws and Brie Falkard and Sophie Adjalley and Fidock, {David A.} and Laurence Berry and Jacobs, {William R.} and Baird, {Mark S.} and Henri Vial and Laurent Kremer",
year = "2009",
month = "9",
day = "3",
doi = "10.1371/journal.pone.0006889",
language = "English (US)",
volume = "4",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "9",

}

TY - JOUR

T1 - Oleic acid biosynthesis in Plasmodium falciparum

T2 - Characterization of the stearoyl-CoA desaturase and investigation as a potential therapeutic target

AU - Gratraud, Paul

AU - Huws, Enlli

AU - Falkard, Brie

AU - Adjalley, Sophie

AU - Fidock, David A.

AU - Berry, Laurence

AU - Jacobs, William R.

AU - Baird, Mark S.

AU - Vial, Henri

AU - Kremer, Laurent

PY - 2009/9/3

Y1 - 2009/9/3

N2 - Background: Plasmodium falciparum parasitization of erythrocytes causes a substantial increase in the levels of intracellular fatty acids, notably oleic acid. How parasites acquire this monounsaturated fatty acid has remained enigmatic. Here, we report on the biochemical and enzymatic characterization of stearoyl-CoA desaturase (SCD) in P. falciparum. Methodology/Principal Findings: Metabolic labeling experiments allowed us to demonstrate the production of oleic acid from stearic acid both in lysates of parasites incubated with [14C]-stearoyl-CoA and in parasite-infected erythrocytes labeled with [14C]-stearic acid. Optimal SCD activity was detected in schizonts, the stage of maximal membrane synthesis. This activity correlated with a late trophozoite stage-specific induction of PFE0555w transcripts. PFE0555w harbors a typical SCD signature. Similar to mammalian SCDs, this protein was found to be associated with the endoplasmic reticulum, as determined with PFE0555w-GFP tagged transgenic P. falciparum. Importantly, these parasites exhibited increased rates of stearic to oleic acid conversion, providing additional evidence that PFE0555w encodes the plasmodial SCD (PfSCD). These findings prompted us to assess the activity of sterculic acid analogues, known to be specific Δ9-desaturase inhibitors. Methyl sterculate inhibited the synthesis of oleic acid both with parasite lysates and infected erythrocytes, most likely by targeting PfSCD. This compound exhibited significant, rapid and irreversible antimalarial activity against asexual blood stages. This parasiticidal effect was antagonized by oleic acid. Conclusion/Significance: Our study provides evidence that parasite-mediated fatty acid modification is important for blood-stage survival and provides a new strategy to develop a novel antimalarial therapeutic based on the inhibition of PfSCD.

AB - Background: Plasmodium falciparum parasitization of erythrocytes causes a substantial increase in the levels of intracellular fatty acids, notably oleic acid. How parasites acquire this monounsaturated fatty acid has remained enigmatic. Here, we report on the biochemical and enzymatic characterization of stearoyl-CoA desaturase (SCD) in P. falciparum. Methodology/Principal Findings: Metabolic labeling experiments allowed us to demonstrate the production of oleic acid from stearic acid both in lysates of parasites incubated with [14C]-stearoyl-CoA and in parasite-infected erythrocytes labeled with [14C]-stearic acid. Optimal SCD activity was detected in schizonts, the stage of maximal membrane synthesis. This activity correlated with a late trophozoite stage-specific induction of PFE0555w transcripts. PFE0555w harbors a typical SCD signature. Similar to mammalian SCDs, this protein was found to be associated with the endoplasmic reticulum, as determined with PFE0555w-GFP tagged transgenic P. falciparum. Importantly, these parasites exhibited increased rates of stearic to oleic acid conversion, providing additional evidence that PFE0555w encodes the plasmodial SCD (PfSCD). These findings prompted us to assess the activity of sterculic acid analogues, known to be specific Δ9-desaturase inhibitors. Methyl sterculate inhibited the synthesis of oleic acid both with parasite lysates and infected erythrocytes, most likely by targeting PfSCD. This compound exhibited significant, rapid and irreversible antimalarial activity against asexual blood stages. This parasiticidal effect was antagonized by oleic acid. Conclusion/Significance: Our study provides evidence that parasite-mediated fatty acid modification is important for blood-stage survival and provides a new strategy to develop a novel antimalarial therapeutic based on the inhibition of PfSCD.

UR - http://www.scopus.com/inward/record.url?scp=70249092571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70249092571&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0006889

DO - 10.1371/journal.pone.0006889

M3 - Article

C2 - 19707292

AN - SCOPUS:70249092571

VL - 4

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 9

M1 - e6889

ER -